Re: Toni K. Choueiri, Thomas Powles, Laurence Albiges, et al. Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma. N Engl J Med 2023;388:1767-78.
| Autor: | Cerrato C; University Hospital Southampton NHS Trust, Southampton, UK., Pradere B; Department of Urology, La Croix Du Sud Hospital, Quint-Fonsegrives, France., Mir MC; Department of Urology, University Hospital de la Ribera, Valencia, Spain. Electronic address: mirmare@yahoo.es. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | European urology [Eur Urol] 2023 Oct; Vol. 84 (4), pp. e93. Date of Electronic Publication: 2023 Jul 11. |
| DOI: | 10.1016/j.eururo.2023.06.027 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Full Text from ScienceDirect